Shangri-La Tibetan Pharmaceuticals, Inc. - FORM S-1 - EX-10.11 - EXHIBIT 10.11 - May 14, 2010

Attached files

file filename
S-1 - FORM S-1 - Shangri-La Tibetan Pharmaceuticals, Inc.ds1.htm
EX-5.2 - EXHIBIT 5.2 - Shangri-La Tibetan Pharmaceuticals, Inc.dex52.htm
EX-1.1 - EXHIBIT 1.1 - Shangri-La Tibetan Pharmaceuticals, Inc.dex11.htm
EX-5.1 - EXHIBIT 5.1 - Shangri-La Tibetan Pharmaceuticals, Inc.dex51.htm
EX-3.I.2 - EXHIBIT 3(I)(2) - Shangri-La Tibetan Pharmaceuticals, Inc.dex3i2.htm
EX-21.1 - EXHIBIT 21.1 - Shangri-La Tibetan Pharmaceuticals, Inc.dex211.htm
EX-23.1 - EXHIBIT 23.1 - Shangri-La Tibetan Pharmaceuticals, Inc.dex231.htm
EX-10.1 - EXHIBIT 10.1 - Shangri-La Tibetan Pharmaceuticals, Inc.dex101.htm
EX-10.2 - EXHIBIT 10.2 - Shangri-La Tibetan Pharmaceuticals, Inc.dex102.htm
EX-10.6 - EXHIBIT 10.6 - Shangri-La Tibetan Pharmaceuticals, Inc.dex106.htm
EX-10.3 - EXHIBIT 10.3 - Shangri-La Tibetan Pharmaceuticals, Inc.dex103.htm
EX-10.9 - EXHIBIT 10.9 - Shangri-La Tibetan Pharmaceuticals, Inc.dex109.htm
EX-10.8 - EXHIBIT 10.8 - Shangri-La Tibetan Pharmaceuticals, Inc.dex108.htm
EX-10.5 - EXHIBIT 10.5 - Shangri-La Tibetan Pharmaceuticals, Inc.dex105.htm
EX-99.2 - EXHIBIT 99.2 - Shangri-La Tibetan Pharmaceuticals, Inc.dex992.htm
EX-3.I.1 - EXHIBIT 3(I)(1) - Shangri-La Tibetan Pharmaceuticals, Inc.dex3i1.htm
EX-99.1 - EXHIBIT 99.1 - Shangri-La Tibetan Pharmaceuticals, Inc.dex991.htm
EX-10.7 - EXHIBIT 10.7 - Shangri-La Tibetan Pharmaceuticals, Inc.dex107.htm
EX-10.4 - EXHIBIT 10.4 - Shangri-La Tibetan Pharmaceuticals, Inc.dex104.htm
EX-10.15 - EXHIBIT 10.15 - Shangri-La Tibetan Pharmaceuticals, Inc.dex1015.htm
EX-10.16 - EXHIBIT 10.16 - Shangri-La Tibetan Pharmaceuticals, Inc.dex1016.htm
EX-10.14 - EXHIBIT 10.14 - Shangri-La Tibetan Pharmaceuticals, Inc.dex1014.htm
EX-10.17 - EXHIBIT 10.17 - Shangri-La Tibetan Pharmaceuticals, Inc.dex1017.htm
EX-10.18 - EXHIBIT 10.18 - Shangri-La Tibetan Pharmaceuticals, Inc.dex1018.htm
EX-10.12 - EXHIBIT 10.12 - Shangri-La Tibetan Pharmaceuticals, Inc.dex1012.htm
EX-3.II.2 - EXHIBIT 3(II)(2) - Shangri-La Tibetan Pharmaceuticals, Inc.dex3ii2.htm
EX-10.19 - EXHIBIT 10.19 - Shangri-La Tibetan Pharmaceuticals, Inc.dex1019.htm
EX-10.13 - EXHIBIT 10.13 - Shangri-La Tibetan Pharmaceuticals, Inc.dex1013.htm
EX-10.10 - EXHIBIT 10.10 - Shangri-La Tibetan Pharmaceuticals, Inc.dex1010.htm
EX-3.II.1 - EXHIBIT 3(II)(1) - Shangri-La Tibetan Pharmaceuticals, Inc.dex3ii1.htm

Exhibit 10.11

Translation of Medicinal Material Procurement Contract

Party A (Purchaser): Yunnan Shangri-La Tibetan Pharmaceutical Group Limited.

Party B (Supplier): Kunming Morningstar Printing Co., Ltd.

 

Product’s Name

    Specification    Unit    Quantity    Unit
Price		    Value (RMB)    Procurement
Period		    Memo

Boxes

       s/es    3,966,659    0.07    262,471.07    09.1.1-12.31   

Instruction Manual

       piece    16,837,993    0.03    432,632,72    09.1.1-12.31   

Packing

       piece    169,365    0.03    4,347.59    09.1.1-12.31   

Cardboard Boxes

       s/es    165,775    7.7    1,276,241.88      

Small Boxes

       s/es    32,240,646    0.13    4,086,583.16    09.1.1-12.31   

Big Boxes

       s/es    13,116,781    0.65    8,506,400.95    09.1.1-12.31   

Sealing Labels

       s/es    43,552,765    0.01    256,455.81    09.1.1-12.31   

The Aggregate Value: RMB 14,825,133.18

The Procurement Place: Yunnan Shangri-La Tibetan Medicine Group Co., Ltd.

Date of Delivery: Delivery within 45 days upon the signature of the Contract

Payment Method: Party A shall make payment of all the accounts payable within 30 days upon the entry of products in the warehouse and Party B shall draw the accounts receivable by presentation of the warehouse voucher.

Quality Standard: State Standard

Package: Polypropylene (PP) Knitted Bag or cloth bag free of any damage.

Quality Requirements by Party B: The products shall comply with the state quality standards as well as the agreed quality standard bases on the said quality standards; Packing Sound

Quality Requirements agreed by Both Parties: The Tibetan medicinal materials standard under the administration authorities of the Ministry of Public Health shall be executed.

Liability of Breach: The breached party shall make the compensation for the non-breach party by the amount equivalent to 30% of the aggregate value of the contract herein.

This contract is in duplicate and shall be effective upon both parties’ signature, seal, and putting one’s fingerprint.

Party A: Yunnan Shangri-La Tibetan Pharmaceutical Group Limited

Authorized Representative: Hong Yu (Signature)

Yunnan Shangri-La Tibetan Pharmaceutical Group Limited (Seal)

Signature Date: Dec 4, 2008

Party B: Kunming Morningstar Printing Co., Ltd.

Authorized Representative: Liu Zhixiang (Signature)

Kunming Morningstar Printing Co., Ltd. (Seal)

Signature Date: Dec 4, 2008

Shangri-La Tibetan Pharmaceuticals, Inc. Reports